galactose has been researched along with cyclosporine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benndorf, R; Greenbaum, LA; Smoyer, WE | 1 |
| Kumar, N; Mishra, PR; Prasad, V | 1 |
| Aldouby, YH; Avramoff, A; Domb, AJ; Khan, W | 1 |
| Gan, L; Liu, Y; Wang, Y; Yang, J; Zhang, H | 1 |
1 review(s) available for galactose and cyclosporine
| Article | Year |
|---|---|
Childhood nephrotic syndrome--current and future therapies.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Child; Cyclophosphamide; Cyclosporine; Enzyme Inhibitors; Galactose; Glucocorticoids; Homeostasis; Humans; Immunologic Factors; Immunosuppressive Agents; Interleukin-13; Intracellular Signaling Peptides and Proteins; MAP Kinase Signaling System; Mycophenolic Acid; Nephrotic Syndrome; p38 Mitogen-Activated Protein Kinases; Plasmapheresis; Protein Serine-Threonine Kinases; Receptors, Notch; Ribonucleosides; Rituximab; Signal Transduction; Tacrolimus; Thiazolidinediones; Unfolded Protein Response | 2012 |
3 other study(ies) available for galactose and cyclosporine
| Article | Year |
|---|---|
Amphiphilic gels as a potential carrier for topical drug delivery.
Topics: Administration, Topical; Animals; Calorimetry, Differential Scanning; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Cyclosporine; Drug Carriers; Drug Delivery Systems; Drug Stability; Erythema; Gels; Hexoses; Immunosuppressive Agents; In Vitro Techniques; Irritants; Polysorbates; Rats; Skin; Sodium Dodecyl Sulfate; Surface-Active Agents | 2007 |
Cyclosporin nanosphere formulation for ophthalmic administration.
Topics: Administration, Ophthalmic; Animals; Anti-Inflammatory Agents; Cyclosporine; Eye; Glycerol; Hexoses; Lecithins; Nanospheres; Pharmaceutical Vehicles; Polysorbates; Propylene Glycol; Rabbits; Solvents; Surface-Active Agents; Triglycerides | 2012 |
Cationized hyaluronic acid coated spanlastics for cyclosporine A ocular delivery: Prolonged ocular retention, enhanced corneal permeation and improved tear production.
Topics: Administration, Ophthalmic; Animals; Cations; Cyclosporine; Drug Liberation; Dry Eye Syndromes; Eye; Hexoses; Hyaluronic Acid; Immunosuppressive Agents; Liposomes; Male; Rabbits; Tears | 2019 |